Vitamin D Deficiency in Human Immunodeficiency Virus
The effect of Cholecalciferol and dietary advice on Vitamin D levels in participants with Human Immunodeficiency Virus Infection
The Alfred Hospital Research Trust
40 participants
Jul 2, 2009
Interventional
Conditions
Summary
The primary purpose of the study is to measure the prevalence of vitamin D deficiency in the HIV population at the Alfred Hospital, and then to evaluate the effectiveness of vitamin D supplementation in this population.
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Supplementation with 5000 IU Cholecalciferol orally, daily for 12 months, in addition to a single 30 minute interview with dietitian at baseline with provision of dietary advice regarding sources of vitamin D in diet plus advice regarding safe levels of sunlight exposure
Locations(1)
View Full Details on ANZCTR
For the most up-to-date information, visit the official listing.
ACTRN12611000631909